Due Diligence and Art
Due Diligence by Sasha Latypova Podcast
TNT Radio - Discussion with Jesse Zurawell, February 14, 2023
0:00
Current time: 0:00 / Total time: -55:48
-55:48

TNT Radio - Discussion with Jesse Zurawell, February 14, 2023

We discuss the regulators violating their own rules, then re-writing their rules to match the violations for their “preferred” mRNA companies, while also simultaneously holding back any other aspiring mRNA pharma developers. My personal opinion, mRNA category has a very long way to go as a medicine, and absolutely should not be allowed for any prophylactic treatment or a treatment that is applied to broad populations due to insurmountable safety and manufacturing issues.

Government investment in mega biopharma manufacturing plants all over the world is another concerning trend - what are they investing in, given that there is hardly any demand anymore for these poisonous injections?

Discussion about this podcast

Due Diligence and Art
Due Diligence by Sasha Latypova Podcast
Uncovering Fraud in Pharmaceutical R&D and Manufacturing